Drug
AM-101
AM-101 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_3
4
80%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 34 (80.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194
completedphase_3
AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207
completedphase_3
AM-101 in the Treatment of Acute Tinnitus 2
NCT01803646
completedphase_3
AM-101 in the Treatment of Post-Acute Tinnitus 1
NCT01934010
completedphase_2
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808
Clinical Trials (5)
Showing 5 of 5 trials
NCT02040194Phase 3
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040207Phase 3
AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT01803646Phase 3
AM-101 in the Treatment of Acute Tinnitus 2
NCT01934010Phase 3
AM-101 in the Treatment of Post-Acute Tinnitus 1
NCT00860808Phase 2
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5